NeuroGastrX

Home - Neurogastrx, Inc.

Woburn, United States · $107.8M raised

Headquarters
Woburn
Employees
1–10
Business Model
B2B
Total Funding
$107.8M
Last Round
$60.0M Series BAug 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Neurogastrx is a private biopharmaceutical company focused on discovering and developing transformative therapies for gastrointestinal disorders affecting the enteric nervous system. It pursues indications for patients with GI diseases that have limited innovation or treatment options, combining that focus with a management team experienced in developing and commercializing GI medicines. Therapeutic areas listed by the company include nausea and vomiting associated with GLP-1 agonists and gastroparesis, with NG101 as a pipeline program. The company lists its address in Woburn, Massachusetts.

Summary

NeuroGastrX is a Biotech company based in Woburn, United States. It has raised $107.8M in total across 3 rounds, most recently a $60.0M Series B round in Aug 2021. Investors include Vivo Capital, 5AM Ventures and OrbiMed.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2021
$60.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NeuroGastrX on Indexed.vc
<a href="https://indexed.vc/companies/neurogastrx"><img src="https://indexed.vc/api/badge/company/neurogastrx" alt="NeuroGastrX on Indexed.vc" width="260" height="76" /></a>